Medical/Scientific Advisors

 

FCF strives to be in the forefront of research on fibrolamellar hepatocellular carcinoma. Several leading physicians, scientists and researchers in this field have agreed to be advisors to FCF. Each represents an institution or laboratory which is currently involved in research or treatment of fibrolamellar liver cancer.

Ghassan Abou-Alfa, M.D.

Attending Physician
Department of Medicine and Gastrointestinal Oncology Service
Memorial Sloan-Kettering Cancer Center, New York

 

chotiMichael Choti, M.D., M.B.A.

Professor and Chairman
Department of Surgery
UT Southwestern Medical Center, Dallas, Texas

 

dematteoRonald P. DeMatteo, M.D., FACS

Vice Chair, Department of Surgery
Head, Division of General Surgical Oncology
Memorial Sloan-Kettering Cancer Center, New York

 

laougliaMichael P. LaQuaglia, M.D., FACS, FRCS

Chief, Pediatric Surgical Service
Memorial Sloan-Kettering Cancer Center, New York

 

levineRon Levine, M.D.

Internist
Greenwich, Connecticut

 

 

JRCphoto - Dr. CraigJohn Craig, M.D.
Pathologist, Director of FCF
Carmel, California

 

 

Lola Reid, PH.D.

Professor
Department of Cell and Molecular Physiology
University of North Carolina, Chapel Hill, NC

 

simonSanford M. Simon, PH.D.

Professor
Head, Laboratory of Cellular Biophysics
The Rockefeller University, New York

 

torbensonMichael Torbenson, M.D.

Senior Associate Consultant
Department of Anatomic Pathology
Mayo Clinic, Rochester, Minnesota

 

Alan P. Venook, M.D.

Professor, Department of Medicine (Hematology/Oncology)
University of California, San Francisco, California